Dr. Michael Barry
Associate Professor, Pharmacology & Therapeutics
Publications and Further Research Outputs
Peer-Reviewed Publications
Abdelaal Ahmed Mahmoud M Alkhatip, A., Conroy, P., Hamza, M.K., Murphy, I., Purcell, A., McGuire, D., The authors reply, Critical Care Medicine, 48, (8), 2020, pE731-E732
Gorry, Claire and Leahy, Joy and Lamrock, Felicity and Walsh, Cathal and White, Arthur and Barry, Michael and McCullagh, Laura, VP82 Impact of Evidence Synthesis Methods on Outcome of Economic Evaluation, International Journal of Technology Assessment in Health Care, 35, (S1), 2019, p93 - 94
Gorry C, McCullagh L, O'Donnell H, Barrett S, Schmitz S, Barry M, Curtin K, Beausang E, Barry R, Coyne I. , Neoadjuvant Treatment for malignant and metastatic melanoma. , Cochrane Database of Systematic Reviews. , (3), 2018
Liddy A.M., McLaughlin G., Schmitz S., D'Arcy D.M., Barry M.G., The pharmacokinetic interaction between ivacaftor and ritonavir in healthy volunteers, British Journal of Clinical Pharmacology, 83, (10), 2017, p2235 - 2241, p2235-2241
Power J.D., Kavanagh P., McLaughlin G., Dowling G., Barry M., O'Brien J., Talbot B., Twamley B., Brandt S.D., Forensic analysis of P2P derived amphetamine synthesis impurities: identification and characterization of indene by-products, Drug Testing and Analysis, 9, (3), 2017, p446 - 452, p446-452
Power J.D., Kavanagh P., McLaughlin G., Barry M., Dowling G., Brandt S.D., `APAAN in the neck" " A reflection on some novel impurities found in seized materials containing amphetamine in Ireland during routine forensic analysis, Drug Testing and Analysis, 9, (7), 2017, p966 - 976, p966-976
Corcoran A, Hickey N, Barry M, Usher C, McCullagh L, Ivacaftor for cystic fibrosis; An evaluation of real world utilisation and expenditure in the Irish Healthcare Setting., Irish Medical Journal, 110, (8), 2017
McCullagh L, Schmitz S, Barry M, Walsh C, Examining the Feasibility and Utility of Estimating Partial Expected Value of Perfect Information (via a Nonparametric Approach) as Part of the Reimbursement Decision-Making Process in Ireland: Application to Drugs for Cancer, PharmacoEconomics, 2017
Usher, C., Adams, R., Schmitz, S., Kieran, J., O'Flanagan, D., O'Donnell, J., Connolly, K., Corcoran, B., Butler, K., Barry, M., Walsh, C., Evaluating the neonatal BCG vaccination programme in Ireland, Archives of Public Health, 74, (1), 2016
Schmitz S, McCullagh L, Adams R, Walsh C, Identifying and Revealing the Importance of Decision-Making Criteria for Health Technology Assessment: A Retrospective Analysis of Reimbursement Recommendations in Ireland, PharmacoEconomics, 2016
Fogarty, E., Schmitz, S., Tubridy, N., Walsh, C., Barry, M., Comparative efficacy of disease-modifying therapies for patients with relapsing remitting multiple sclerosis: Systematic review and network meta-analysis, Multiple Sclerosis and Related Disorders, 9, 2016, p23-30
McCullagh L, Barry M, The Pharmacoeconomic Evaluation Process in Ireland, PharmacoEconomics, 34, (12), 2016, p1267 - 1276
Sandys, V., Barry, M., The use of aspirin in primary prevention of cardiovascular disease, Irish Medical Journal, 109, (3), 2016, p368
Morgan RB, McCullagh L, Barry M, Daly C, The cost of inpatient management of heart failure patients: a microcosting study in the Irish healthcare setting., 2016
Reddy, B.P., Adams, R., Walsh, C., Barry, M., Kind, P., Using the Analytic Hierarchy Process to Derive Health State Utilities from Ordinal Preference Data, Value in Health, 18, (6), 2015, p841-845
Kieran JA, Norris S, O'Leary A, Walsh C, Merriman R, Houlihan D, McCormick PA, McKiernan S, Bergin C, Barry M, Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study., BMC infectious diseases, 15, 2015, p471
O'Mahony, L., Liddy, A.-M., Barry, M., Bennett, K., Hormonal contraceptive use in Ireland: Trends and co-prescribing practices, British Journal of Clinical Pharmacology, 80, (6), 2015, p1315-1323
Power J., Power J., Kavanagh P., Mclaughlin G., O'Brien J., Talbot B., Barry M., Twamley B., Dowling G., Brandt S., Identification and characterization of an imidazolium by-product formed during the synthesis of 4-methylmethcathinone (mephedrone), Drug Testing and Analysis, 7, (10), 2015, p894-902
O'Leary, A., Usher, C., Lynch, M., Hall, M., Hemeryk, L., Spillane, S., Gallagher, P., Barry, M., Generic medicines and generic substitution: Contrasting perspectives of stakeholders in Ireland, BMC Research Notes, 8, (1), 2015
Ledwidge, M.T., O'Connell, E., Gallagher, J., Tilson, L., James, S., Voon, V., Bermingham, M., Tallon, E., Watson, C., O'Hanlon, R., Barry, M., McDonald, K., Cost-effectiveness of natriuretic peptide-based screening and collaborative care: A report from the STOP-HF (St Vincent's Screening to Prevent Heart Failure) study, European Journal of Heart Failure, 17, (7), 2015, p672-679
Kieran, J., Bennett, K., Coghlan, M., Bergin, C., Barry, M., The budget impact of hepatitis C treatment in Ireland 2001-2012, Irish Medical Journal, 108, (6), 2015, p1-2
O'Brien C, Fogarty E, Walsh C, Dempsey O, Barry M, Kennedy MJ, McCullagh L, The cost of the inpatient management of febrile neutropenia in cancer patients - a micro-costing study in the Irish healthcare setting. , European Journal of Cancer Care, 2014
McLaughlin, J., Surah, S., Synnott, C., Adams, R., Walsh, C., O'Dea, S., Noone, S., Keenan, E., Keating, S., Barry, M., Bergin, C., Mulcahy, F., Lyons, F., Health-related quality of life of patients on opiate replacement therapy, Heroin Addiction and Related Clinical Problems, 16, (4), 2014, p25-32
Power JD, Kavanagh P, O'Brien J, Barry M, Twamley B, Talbot B, Dowling G, Brandt SD, Test purchase, identification and synthesis of 2-amino-1-(4-bromo-2, 5-dimethoxyphenyl)ethan-1-one (bk-2C-B)., Drug testing and analysis, 2014
Scott KR, Power JD, McDermott SD, O'Brien JE, Talbot BN, Barry MG, Kavanagh PV, Identification of (2-aminopropyl)indole positional isomers in forensic samples., Drug testing and analysis, 6, (7-8), 2014, p598-606
Power JD, Barry MG, Scott KR, Kavanagh PV, An unusual presentation of a customs importation seizure containing amphetamine, possibly synthesized by the APAAN-P2P-Leuckart route., Forensic science international, 234, 2014, pe10-3
Fogarty E, Walsh C, McGuigan C, Tubridy N, Barry M, Direct and Indirect Economic Consequences of Multiple Sclerosis in Ireland., Applied health economics and health policy, 2014
Power JD, O'Brien J, Talbot B, Barry M, Kavanagh P, The identification of an impurity product, 4,6-dimethyl-3,5-diphenylpyridin-2-one in an amphetamine importation seizure, a potential route specific by-product for amphetamine synthesized by the APAAN to P2P, Leuckart route., Forensic science international, 241, 2014, pe13-9
Power JD, Clarke K, McDermott SD, McGlynn P, Barry M, White C, O'Brien J, Kavanagh P, The identification of 4-methylamphetamine and its synthesis by-products in forensic samples., Forensic science international, 228, (1-3), 2013, p115-31
Kieran JA, Schmitz S, O'Leary A, Walsh C, Bergin C, Norris S, Barry MG, Reply to Calgano, et al., Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013
Sharp, L., Walsh, C., Whyte, S., Tilson, L., O'Ceilleachair, A., Usher, C., Tappenden, P., Chilcott, J., Staines, A., Barry, M., Comber, H., Reply: Cost-effectiveness of population-based screening for colorectal cancer, British Journal of Cancer, 108, (5), 2013, p1211-1212
Barry, M., New oral anticoagulants for non-valvular atrial fibrillation safety issues, Irish Medical Journal, 106, (3), 2013, p1
Nicholas Brown, 'Medicatio', Interactive sound installation. Exhibited as part of 'From Birdsong to Light', Hungate Medieval Art, St Peter Hungate, Norwich, 2013, -
Sharp, L., Tilson, L., Whyte, S., Ceilleachair, A.O., Walsh, C., Usher, C., Tappenden, P., Chilcott, J., Staines, A., Barry, M., Comber, H., Using resource modelling to inform decision making and service planning: The case of colorectal cancer screening in Ireland, BMC Health Services Research, 13, (1), 2013
Ledwidge, M., Gallagher, J., Conlon, C., Tallon, E., O'Connell, E., Dawkins, I., Watson, C., O'Hanlon, R., Bermingham, M., Patle, A., Badabhagni, M.R., Murtagh, G., Voon, V., Tilson, L., Barry, M., McDonald, L., Maurer, B., McDonald, K., Natriuretic peptide-based screening and collaborative care for heart failure: The STOP-HF randomized trial, JAMA - Journal of the American Medical Association, 310, (1), 2013, p66-74
Surah S, Adams R, Townsend L, Reynolds I, Kinahan JC, Keating S, Mulcahy F, Keenan E, Barry M, Lyons F, Health-related quality of life of HIV-infected intravenous drug users., International journal of STD & AIDS, 2013
Fogarty E, Walsh C, Adams R, McGuigan C, Barry M, Tubridy N, Relating health-related Quality of Life to disability progression in multiple sclerosis, using the 5-level EQ-5D., Multiple sclerosis (Houndmills, Basingstoke, England), 19, (9), 2013, p1190-6
Kieran J, Schmitz S, O'Leary A, Walsh C, Bergin C, Norris S, Barry M, The relative efficacy of boceprevir and telaprevir in the treatment of hepatitis C virus genotype 1., Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 56, (2), 2013, p228-35
McCullagh L, Barry M, Prescribing trends for dabigatran etexilate in primary care., 2012
McCullagh L, Walsh C, Barry M , Value-of-Information Analysis to Reduce Decision Uncertainty Associated with the Choice of Thromboprophylaxis after Total Hip Replacement in the Irish Healthcare Setting., PharmacoEconomics, 30, (10), 2012, p941 - 959
Schmitz, Susanne; Adams, Roisin; Walsh, Cathal D; Barry, Michael; FitzGerald, Oliver; , A mixed treatment comparison of the efficacy of anti-TNF agents in rheumatoid arthritis for methotrexate non-responders demonstrates differences between treatments: a Bayesian approach, Annals of the rheumatic diseases, 71, (2), 2012, p225 - 230
Hiligsmann M, McGowan B, Bennett K, Barry M, Reginster JY, The clinical and economic burden of poor adherence and persistence with osteoporosis medications in Ireland., Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 15, (5), 2012, p604-12
Tilson, L; Sharp, L; Usher, C; Walsh, C; O'ÄôCeilleachair, A; Stuart, C; Mehigan, B; John Kennedy, M; Tappenden, P; Chilcott, J; , Cost of care for colorectal cancer in Ireland: a health care payer perspective, The European Journal of Health Economics, 13, (4), 2012, p511 - 524
Sharp, L; Tilson, L; Whyte, S; O'Ceilleachair, A; Walsh, C; Usher, C; Tappenden, P; Chilcott, J; Staines, A; Barry, M; , Cost-effectiveness of population-based screening for colorectal cancer: a comparison of guaiac-based faecal occult blood testing, faecal immunochemical testing and flexible sigmoidoscopy, British Journal of Cancer, 106, 2012, p805 - 816
Usher C, Tilson L, Bennett K, Barry M, Cost containment interventions introduced on the community drugs schemes in Ireland-evaluation of expenditure trends using a national prescription claims database., Clinical therapeutics, 34, (3), 2012, p632-9
Usher, C., Barry, M., A reference pricing system for Ireland, Expert Review of Pharmacoeconomics and Outcomes Research, 12, (6), 2012, p675-677
L. Tilson, M. Jit, S. Schmitz, C. Walsh, P. Garvey, P. McKeown, M. Barry, Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in Ireland, Vaccine, 29, (43), 2011, p7463 - 7473
Adams, R., Craig, B.M., Walsh, C.D., Veale, D.J., Bresnihan, B., Fitzgerald, O., Barry, M., The impact of a revised EQ-5D population scoring on preference-based utility scores in an inflammatory arthritis cohort, Value in Health, 14, (6), 2011, p921-927
Fogarty, E., Tilson, L., Ryan, M., Barry, M., Health Technology Assessment International 7th Annual Meeting, Expert Review of Pharmacoeconomics and Outcomes Research, 10, (5), 2010, p501-503
Barry, M., Usher, C., Tilson, L., Public drug expenditure in the Republic of Ireland, Expert Review of Pharmacoeconomics and Outcomes Research, 10, (3), 2010, p239-245
McGowan B, Bennett K, Barry M., Prescribing of anti-osteoporotic therapies following the use of proton pump inhibitors in general practice., Pharmacoepidemiol Drug Saf, 19, (7), 2010, p763 - 769
Tilson, L., Barry, M., Recent developments in pharmacoeconomic evaluation in Ireland, Expert Review of Pharmacoeconomics and Outcomes Research, 10, (3), 2010, p221-224
Barry, M., Tilson, L., Reimbursement of new high cost drugs - funding the unfundable?, Irish Medical Journal, 103, (5), 2010
Adams R, Walsh C, Veale D, Bresnihan B, Fitzgerald O, Barry M, Understanding the Relationship between the EQ-5D, SF-6D, HAQ and Disease Activity in Inflammatory Arthritis., PharmacoEconomics, 28, (6), 2010, p477-87
Tilson, L., O'Leary, A., Usher, C., Barry, M., Pharmacoeconomic evaluation in Ireland: A review of the process, PharmacoEconomics, 28, (4), 2010, p307-322
Barry, M., Dabigatran versus warfarin in patients with atrial fibrillation, New England Journal of Medicine, 361, (27), 2009, p2674
Kerner, J.F., Cazap, E., Yach, D., Pierotti, M.A., Daidone, M.G., De Blasio, P., Geary, P., Schacter, B., Sant, M., Habbema, J.D.F., Sankaranarayanan, R., Sutcliffe, C., Sutcliffe, S., Kaijage, J.K., Scanlan, P.A., Gibson, S., Mes-Masson, A.M., Sawyer, M., Shepherd, L., Watson, P., Zanke, B., Small, I.A., Olmedo, D.B., Breitenbach, M.D., Santini, L.A., Maltoni, L.A., Ramalho, D., Ferreira, C.G., Sharp, L., Cruickshank, M., Smart, L., Harrild, K., Waugh, N., Little, J., Seth, R., Neal, K., Duncan, I., Ioka, A., Ito, Y., Sato, N., Tsukuma, H., Li, J., Zhang, B.N., Fan, J.H., Qiao, Y.L., Zhong, H.Y., Curado, M.P., Pontes, T.J.S., Peacock, S., Van Der Hoek, K., Hoch, J., Musa, Z., Weir, H.K., Friedman, C., German, R., Ceilleachair, A.O., Comber, H., Cotton, S., Tilson, L., Walsh, C., Usher, C., Barry, M., Chilcott, J., Tappenden, P., Whyte, S., Staines, A., Greenberg, A., Fairclough, L., Roberts, W., Masterson Tavares Pereira Ferrera, D., Fonseca, E.R., Casado, L., McBride, M.L., Goddard, K., Lorenzi, M., Spinelli, J.J., Broemeling, A.M., Glickman, V., Pritchard, S., Siegel, L., Rogers, P.C., Sheps, S., Annunziata, M.A., Giovannini, L., Bianchet, K., Muzzatti, B., Berretta, M., Lleshi, A., Tirelli, U., Sisimayi, C.N., Sarwal, K., Torrance, H., Baili, P., Amati, C., Di Salvo, F., Frazzingaro, C., Sanz, N., Micheli, A., Comprehensive cancer control-research & development: Knowing what we do and doing what we know, Tumori, 95, (5), 2009, p610-622
Bennett K, Kabir Z, Barry M, Tilson L, Fidan D, Shelley E, Capewell S., Cost-Effectiveness of Treatments Reducing Coronary Heart Disease Mortality in Ireland, 2000 to 2010., Value Health., 12, (1), 2009, p10-15
McCullagh L, Tilson L, Walsh C, Barry M, A cost-effectiveness model comparing rivaroxaban and dabigatran etexilate with enoxaparin sodium as thromboprophylaxis after total hip and total knee replacement in the irish healthcare setting., 2009
Barry, M., Molloy, D., Usher, C., Tilson, L., Drug expenditure in Ireland 1997 - 2007, Irish Medical Journal, 101, (10), 2008
McGowan B, Bergin C, Bennett K, Barry M., Utilisation of antibiotic therapy in community practice., Irish Medical Journal, 101, (9-10), 2008, p273-276
Tilson, L., Usher, C., Butler, K., Fitzsimons, J., O'Hare, F., Cotter, S., O'Flanagan, D., Johnson, H., Barry, M., Economic evaluation of a universal childhood pneumococcal conjugate vaccination strategy in Ireland, Value in Health, 11, (5), 2008, p898-903
Cara Usher, Lesley Tilson, Jens Olsen, Martin Jepsen, Cathal Walsh, Michael Barry, Cost-effectiveness of human papillomavirus vaccine in reducing the risk of cervical cancer in Ireland due to HPV types 16 and 18 using a transmission dynamic model, Vaccine, 26, (44), 2008, p5654 - 5661
McGowan B, Bennett K, Barry M, Canny M., The utilisation and expenditure of medicines for the prophylaxis and treatment of osteoporosis., Irish Medical Journal, 101, (2), 2008, p38-41.
Ryan, M., Griffin, S., Chitah, B., Walker, A.S., Mulenga, V., Kalolo, D., Hawkins, N., Merry, C., Barry, M.G., Chintu, C., Sculpher, M.J., Gibb, D.M., The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia, AIDS, 22, (6), 2008, p749-757
Tilson, L., Thornton, L., O'Flanagan, D., Johnson, H., Barry, M., Cost effectiveness of hepatitis B vaccination strategies in Ireland: An economic evaluation, European Journal of Public Health, 18, (3), 2008, p275-282
Barry, M., Tilson, L., Recent developments in pricing and reimbursement of medicines in Ireland, Expert Review of Pharmacoeconomics and Outcomes Research, 7, (6), 2007, p605-611
Falconer, M., Molloy, D., Ingerhaug, J., Barry, M., Methadone induced torsade de pointes in a patient receiving antiretroviral therapy, Irish Medical Journal, 100, (10), 2007
Walshe V, O'Morain C, Bennett K, Keeling PW, Barry M, Best practice' for Helicobacter pylori eradication in the primary care setting, Irish Medical Journal, 99, (1), 2006, p11 - 12
Knox, F.A., Barry, M., McGowan, B., O'Brien, C., The rising cost of glaucoma drugs in Ireland 1996-2003, British Journal of Ophthalmology, 90, (2), 2006, p162-165
Song,G.; Hennessy,M.; Zhao,Y.L.; Li,Q.; Han,W.D.; Qi,Y.; Zhao,W.N.; Silke,B.; Barry,M.; Doyle,R.; Spiers,J.P., Adrenoceptor blockade alters plasma gelatinase activity in patients with heart failure and MMP-9 promoter activity in a human cell line (ECV304), Pharmacological Research, 54, 2006, p57 - 64
B. McGowan, K. Bennett, L. Tilson, M. Barry, Cost effective prescribing of proton pump inhibitors (PPI's) in the GMS Scheme, Irish Medical Journal, 98, (3), 2005, p78 - 80
L. Tilson, K. Bennett, M. Barry, The potential impact of implementing a system of generic substitution on the community drug schemes in Ireland, European Journal of Health Economics, 6, (3), 2005, p267 - 273
Feely J, Barry M., Adverse Drug Interactions, Clinical Medicine , (5), 2005, p19 - 22
McCann S., Foà R., Smith O. and Conneally E.., Case-Based Haematology. , Blackwell publishing Ltd, 2005
Hennessy,M.; Clarke,S.; Spiers,J.P.; Kelleher,D.; Mulcahy,F.; Hoggard,P.; Back,D.; Barry,M., Intracellular accumulation of nelfinavir and its relationship to P-glycoprotein expression and function in HIV infected patients, Antiviral Therapy, 9, 2004, p115 - 122
Barry, M., Tilson, L., Ryan, M., Pricing and reimbursement of drugs in Ireland, European Journal of Health Economics, 5, (2), 2004, p190-194
Barry, M., Prevention of postoperative nausea and vomiting, Irish Medical Journal, 97, (10), 2004, p293
Barry, M., Rosuvastatin-warfarin drug interaction [1], Lancet, 363, (9405), 2004, p328
Ryan M, Merry C, Ryan C, Bennett K, Heerey A, McGowan B, Mulcahy F, Barry M., Population based study of the cost of inpatient care for HIV infected individuals in an Irish teaching hospital, IMJ, 97, (7), 2004, p200 - 202
L Tilson, K Bennett, M Barry, Prescribing trends for nicotine replacement therapy in primary care, Irish Medical Journal, 97, (9), 2004, p270 - 273
Barry, M., Tilson, L., Ryan, M., Patient co-payment for prescription medicines accross Europe - How do we compare?, Irish Medical Journal, 97, (3), 2004, p69-70
Langan, S.M., Heerey, A., Barry, M., Barnes, L., Cost analysis of narrowband UVB phototherapy in psoriasis, Journal of the American Academy of Dermatology, 50, (4), 2004, p623-626
Tilson, L., McGowan, B., Bennett, K., Barry, M., The high cost of medicines in Ireland. Is it time to change the pricing mechanism?, European Journal of Health Economics, 5, (4), 2004, p341-344
Hennessy,M.; Clarke,S.; Spiers,J.P.; Mulcahy,F.; Kelleher,D.; Meadon,E.; Maher,B.; Bergin,C.; Tjia,J.; Hoggard,P.; Back,D.; Barry,M., Intracellular indinavir pharmacokinetics in HIV infected patients: comparison with plasma pharmacokinetics, Antiviral Therapy, 8, 2003, p191 - 198
Barry, M., PharmacoEconomics: Foreword, PharmacoEconomics, 21, (SUPPL. 1), 2003
Tilson, L., McGowan, B., Ryan, M., Barry, M., Cost-effectiveness of spironolactone in patients with severe heart failure, Irish Journal of Medical Science, 172, (2), 2003, p70-72
Ledwidge, M., Barry, M., Cahill, J., Ryan, E., Maurer, B., Ryder, M., Travers, B., Timmons, L., McDonald, K., Is multidisciplinary care of heart failure cost-beneficial when combined with optimal medical care?, European Journal of Heart Failure, 5, (3), 2003, p381-389
Tilson, L., McGowan, B., Ryan, M., Barry, M., Generic drug utilisation on the General Medical Services (GMS) scheme in 2001, Irish Medical Journal, 96, (6), 2003, p176-179
Sáinz, M., Carvajal, A., Folino Gallo, P., García del Pozo, J., Rosían, I., Vogler, S., vander Stitchele, R., Larsen, L., Ødegaard, B., Brahm, A.K., Martikainen, J., van Ganse, E., Pietri, G., Schwabe, U., Linos, A., Riza, E., Barry, M., Tilson, L., Folino, P., Palazzo, F., Stirparo, G., Righi, A., Bruzzone, M., Puca, E., Martin, N., Ozolins, G., Jansen, P., Rønning, M., Litleskare, I., Vaz, A.F., Antonio, A., Antonov, K., Carlsten, A., Walley, T., deJoncheere, K., Availability of drugs in the European Union. The case of antiplatelet agents [1],Oferta d medicamentos en la Unión Europa. El caso de los antiagregantes plaquetarios, Medicina Clinica, 120, (20), 2003, p793-794
Rosian, I., Vogler, S., vander Stichele, R., Larsen, L., Ødegaard, B., Brahm, A.K., Martikainen, J., van Ganse, E., Pietri, G., Schwabe, U., Schröder, H., Linos, A., Riza, E., Barry, M., Tilson, L., Folino, P., Palazzo, F., Stirparo, G., Righi, A., Bruzzone, M., Puca, E., Martini, N., Addis, A., Ozolins, G., Jansen, P., Rønning, M., Litleskare, I., Faria Vaz, A., Antonio, A., Carvajal, A., Sainz, M., Antonov, K., Carlsten, A., Walley, T., deJoncheere, K., EURO-MED-STAT: Monitoring expenditure and utilization of medicinal products in the European Union countries: A public health approach, European Journal of Public Health, 13, (3), 2003, p95-100
Barry, M., Cost effectiveness of beta blocker therapy for patients with chronic severe heart failure in Ireland, Irish Medical Journal, 95, (6), 2002, p174-177
Clarke, S., Mulcahy, F., Bergin, C., Reynolds, H., Boyle, N., Barry, M., Back, D.J., Absence of opioid withdrawal symptoms in patients receiving methadone and the protease inhibitor lopinavir-ritonavir, Clinical Infectious Diseases, 34, (8), 2002, p1143-1145
Barry, M., Drug expenditure in Ireland 1991-2001., Irish medical journal, 95, (10), 2002, p294-295
Heerey, A., McGowan, B., Ryan, M., Barry, M., Microcosting versus DRGs in the provision of cost estimates for use in pharmacoeconomic evaluation, Expert Review of Pharmacoeconomics and Outcomes Research, 2, (1), 2002, p29-33
Barry, M., Heerey, A., Cost effectiveness of statins for the secondary prevention of coronary heart disease in Ireland, Irish Medical Journal, 95, (5), 2002, p133-135
Clarke S, Keenan E, Ryan M, Barry M, Mulcahy F, Directly observed antiretroviral therapy for injection drug users with HIV infection., The AIDS reader, 12, (7), 2002, p305-7, 312-6
Feely, J., Kavanagh, P., Barry, M., Spiers, J.P., Hennessy, M., St. John's Wort increases expression of P-glycoprotein: Implications for drug interactions, British Journal of Clinical Pharmacology, 53, (1), 2002, p75-82
Clarke S.M., Mulcahy F.M., Tjia J., Reynolds H.E., Gibbons S.E., Barry M.G., Back D.J., Pharmacokinetic interactions of nevirapine and methadone and guidelines for use of nevirapine to treat injection drug users, Clinical Infectious Diseases, 33, (9), 2001, p1595 - 1597, p1595-1597
Barry, M., The price of a research subject, Irish Medical Journal, 94, (4), 2001, p100-101
Clarke, S.M., Mulcahy, F.M., Tjia, J., Reynolds, H.E., Gibbons, S.E., Barry, M.G., Back, D.J., The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz, British Journal of Clinical Pharmacology, 51, (3), 2001, p213-217
Hoggard, P.G., Lloyd, J., Khoo, S.H., Barry, M.G., Dann, L., Gibbons, S.E., Wilkins, E.G., Loveday, C., Back, D.J., Zidovudine phosphorylation determined sequentially over 12 months in human immunodeficiency virus-infected patients with or without previous exposure to antiretroviral agents, Antimicrobial Agents and Chemotherapy, 45, (3), 2001, p976-980
A. Heerey, B. McGowan, M. Ryan, M. Walsh, J. Feely, M. Barry, Cost of treating acute myocardial infarction in an Irish teaching hospital, Irish Journal of Medical Science, 94, 2001, p144 - 146
Clarke S., Harrington P., Barry M., Mulcahy F., The tolerability of Efavirenz post Nevirapine related adverse events, Clinical Infectious Diseases , 2000, p806 - 807
Heerey A, Barry M, Ryan M, Kelly A. , The potential for drug interactions with statin therapy in Ireland., Irish Journal of Medical Science, 169, (3), 2000, p176 - 179
Barry, M., Feely, J., Pharmacoeconomics in Ireland: Concepts and terminology, Irish Journal of Medical Science, 169, (1), 2000, p63-64
Grasela, D.M., Stoltz, R.R., Barry, M., Bone, M., Mangold, B., O'Grady, P., Raymond, R., Haworth, S.J., Pharmacokinetics of single-dose oral stavudine in subjects with renal impairment and in subjects requiring hemodialysis, Antimicrobial Agents and Chemotherapy, 44, (8), 2000, p2149-2153
Back DJ, Gibbons SE, Khoo SH, Barry MG, Merry C, Therapeutic Drug Monitoring Of Antiretrovirals In Human /immunodeficiency Virus Infection, Ther Drug Monitoring, 22, (1), 2000, p122 - 126
McGowan, B., Heerey, A., Ryan, M., Barry, M., Cost of treating heart failure in an Irish teaching hospital, Irish Journal of Medical Science, 169, (4), 2000, p241-244
Barry, M., Heerey, A., Sheehan, O., Ryan, M., McCulloch, D., Feely, J., Pharmacoeconomics of lipid lowering therapy in Ireland, Irish Medical Journal, 92, (7), 1999, p430-432
Barry, M., Mulcahy, F., Merry, C., Gibbons, S., Back, D., Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection, Clinical Pharmacokinetics, 36, (4), 1999, p289-304
Kewn, S., Hoggard, P.G., Henry-Mowatt, J.S., Veal, G.J., Sales, S.D., Barry, M.G., Back, D.J., Intracellular activation of 2',3'-dideoxyinosine and drug interactions in vitro, AIDS Research and Human Retroviruses, 15, (9), 1999, p793-802
Moore, K.H.P., Barrett, J.E., Shaw, S., Pakes, G.E., Churchus, R., Kapoor, A., Lloyd, J., Barry, M.G., Back, D., The pharmacokinetics of lamivudine phosphorylation in peripheral blood mononuclear cells from patients infected with HIV-1, AIDS, 13, (16), 1999, p2239-2250
Barry MG, Heerey A, McCulloch D, Ryan M, Merry C, The Irish National Center Of Pharmacoeconomics - Its Rationale And Role, Irish Medical Journal, 92, (4), 1999, p337 - 339
Merry C, Barry MG, Ryan M, Tjia JF, Hennessy M, Eagling VA, Mulcahy F, Back DJ, Interaction of sildenafil and indinavir when co-administered to HIV-positive patients., AIDS (London, England), 13, (15), 1999, pF101-7
Barry M., Clarke S., Mulcahy F., Back D., Hydroxyurea induced neurotoxicity in HIV disease, Hydroxyurea induced neurotoxicity in HIV disease, 13, (12), 1999, p1592 - 1594
Barry MG, Merry C, Llyod J, Halifax K, Variability Of Trough Plasma Saquinavir Concentrations In HIV Patients - A Case For Therapeutic Drug Monitoring, British Journal Of Clinical Pharmacology, 45, (5), 1998, p501 - 502
Merry C, Barry MG, Ryan M, Ritonavir Pharmacokinetics Alone & In Combination With Saquinavir In HIV-Infected Patients, AIDS, (12), 1998, p325 - 327
Mulcahy FM, Barry MG, Merry C, Nelfinavir And Nevirapine Interaction?, AIDS, (12), 1998, p2361 - 2361
Barry, M., Mulcahy, F., Back, D.J., Antiretroviral therapy for patients with HIV disease, British Journal of Clinical Pharmacology, 45, (3), 1998, p221-228
Hoggard, P.G., Manion, V., Barry, M.G., Back, D.J., Effect of protease inhibitors on nucleoside analogue phosphorylation in vitro, British Journal of Clinical Pharmacology, 45, (2), 1998, p164-167
Merry, C., Barry, M.G., Mulcahy, F., Ryan, M., Tjia, J.F., Halifax, K.L., Breckenridge, A.M., Back, D.J., The pharmacokinetics of combination therapy with nelfinavir plus nevirapine, AIDS, 12, (10), 1998, p1163-1167
Fitzgerald M. , Drug use in Ireland, 10th Conference of the European Child Psychiatry Research Group, Paris, France, October, 1998, pp7
Barry, M., Fiddian, P., McDade, H.B., Clinical pharmacology in the evaluation of new antiviral agents, International Journal of Pharmaceutical Medicine, 11, (6), 1997, p305-309
Hoggard, P.G., Kewn, S., Barry, M.G., Khoo, S.H., Back, D.J., Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro, Antimicrobial Agents and Chemotherapy, 41, (6), 1997, p1231-1236
McDade, H.B., O'Hare, M., Barry, M., Fiddian, P., Gabbay, F.J., Grundy, J.E., Kinghorn, G.R., Main, J., Nicholson, K.G., Peckham, C., Penn, C., Snell, N.J.C., Wood, M.J., The clinical evaluation of antiviral agents, Journal of Antimicrobial Chemotherapy, 40, (SUPPL. B), 1997, p1-67
Merry, C., Mulcahy, F., Barry, M., Gibbons, S., Back, D., Saquinavir interaction with midazolam: Pharmacokinetic considerations when prescribing protease inhibitors for patients with HIV disease [13], AIDS, 11, (2), 1997, p268-269
Kewn, S., Veal, G.J., Hoggard, P.G., Barry, M.G., Back, D.J., Lamivudine (3TC) phosphorylation and drug interactions in vitro, Biochemical Pharmacology, 54, (5), 1997, p589-595
Veal, G.J., Barry, M.G., Khoo, S.H., Back, D.J., In vitro screening of nucleoside analog combinations for potential use in anti-HIV therapy, AIDS Research and Human Retroviruses, 13, (6), 1997, p481-484
Merry C, Barry MG, Mulcahy FM, Saquinavir Pharmacokinetics Alone And In Combination With Nelfinavir In HIV-Infected Patients, AIDS, 1997, p117 - 120
Barry, M., Gibbons, S., Back, D., Mulcahy, F., Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations, Clinical Pharmacokinetics, 32, (3), 1997, p194-209
Merry C, Barry MG, Mulcahy FM, Saquinavir Pharmacokinetics Alone And In Combination With Ritonavir In HIV Infected Patients, AIDS, 1997, p29 - 33
Eagling, V.A., Back, D.J., Barry, M.G., Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir, British Journal of Clinical Pharmacology, 44, (2), 1997, p190-194
Veal, G.J., Hoggard, P.G., Barry, M.G., Khoo, S., Back, D.J., Interaction between lamivudine (3TC) and other nucleoside analogues for intracellular phosphorylation [2], AIDS, 10, (5), 1996, p546-548
Pirmohamed, M., Williams, D., Tingle, M.D., Barry, M., Khoo, S.H., O'Mahony, C., Wilkins, E.G.L., Breckenridge, A.M., Park, B.K., Intracellular glutathione in the peripheral blood cells of HIV-infected patients: Failure to show a deficiency, AIDS, 10, (5), 1996, p501-507
Hoggard, P., Khoo, S., Barry, M., Back, D., Merrill, D.P., Chou, T.-C., Hirsch, M.S., Intracellular metabolism of zidovudine and stavudine in combination [3], Journal of Infectious Diseases, 174, (3), 1996, p671-672
Barry, M.G., Khoo, S.H., Veal, G.J., Hoggard, P.G., Gibbons, S.E., Wilkins, E.G.L., Williams, O., Breckenridge, A.M., Back, D.J., The effect of zidovudine dose on the formation of intracellular phosphorylated metabolites, AIDS, 10, (12), 1996, p1361-1367
Merry C, Barry MG, Mulcahy FM, Back DJ, Improved tolerability of ritonavir derived from pharmacokinetic principles, British Journal Of Clinical Pharmacology, 42, 1996, p787 - 787
Hoggard, P.G., Veal, G.J., Wild, M.J., Barry, M.G., Back, D.J., Drug interactions with zidovudine phosphorylation in vitro, Antimicrobial Agents and Chemotherapy, 39, (6), 1995, p1376-1378
Gibb, D., Barry, M., Ormesher, S., Nokes, L., Seefried, M., Giaquinto, C., Back, D., Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in children with HIV infection., British Journal of Clinical Pharmacology, 39, (5), 1995, p527-530
Veal, G.J., Barry, M.G., Back, D.J., Zalcitabine (ddC) phosphorylation and drug interactions, Antiviral Chemistry and Chemotherapy, 6, (6), 1995, p379-384
Barry, M., Back, D., Breckenridge, A., Zidovudine therapy in HIV infection: which patients should be treated and when., British Journal of Clinical Pharmacology, 40, (2), 1995, p107-110
Veal, G., Wild, M., Barry, M., Back, D., Effects of dideoxyinosine and dideoxycytidine on the intracellular phosphorylation of zidovudine in human mononuclear cells., British Journal of Clinical Pharmacology, 38, (4), 1994, p323-328
Barry, M., Howe, J., Back, D., Swart, A., Breckenridge, A., Weller, I., Beeching, N., Nye, F., Zidovudine pharmacokinetics in zidovudine"induced bone marrow toxicity., British Journal of Clinical Pharmacology, 37, (1), 1994, p7-12
Barry, M., Wild, M., Veal, G., Back, D., Breckenridge, A., Fox, R., Beeching, N., Nye, F., Carey, P., Timmins, D., Zidovudine phosphorylation in HIV-infected patients and seronegative volunteers, AIDS, 8, (8), 1994
Barry, M., Howe, J.L., Back, D.J., Han, I., Gibb, D., Pharmacokinetics of Zidovudine in Children with Symptomatic HIV Infection, Drug Investigation, 7, (3), 1994, p143-147
Barry, M., Howe, J., Ormesher, S., Back, D., Breckenridge, A., Bergin, C., Mulcahy, F., Beeching, N., Nye, F., Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in patients with the acquired immunodeficiency syndrome., British Journal of Clinical Pharmacology, 37, (5), 1994, p421-426
Barry, M., Back, D., Ormesher, S., Beeching, N., Nye, F., Metabolism of didanosine (ddI) by erythrocytes: pharmacokinetic implications [letter], British Journal of Clinical Pharmacology, 36, (1), 1993, p87-88
S. O'Byrne, M. Barry, WCJ Collins, P. O'Connor, M.J. Cullen, J. Feely, Plasma protein binding of lidocaine and warfarin in insulin-dependent and non-insulin-dependent diabetes mellitus, Clinical Pharmacokinetics , 24, 1993, p183 - 186
Barry, M., Howe, J., Back, D., Breckenridge, A., Brettle, R., Mitchell, R., Beeching, N., Nye, F., The effects of indomethacin and naproxen on zidovudine pharmacokinetics., British Journal of Clinical Pharmacology, 36, (1), 1993, p82-85
J. Feely, M. Barry, P.W. Keeling, D.G. Weir, T. Cooke, Lipoprotein(a) in cirrhosis, British Medical Journal, 304, 1992, p545 - 546
Barry, M., Interactions of drugs with alcohol, Practitioner, 235, (1500), 1991, p270-272
P. Holland, M. Barry, J. Feely, Pharmacogenetics and Drug Metabolism: An Irish Perspective, Irish Journal of Medical Science, 160, 1991, p54 - 56
M. Barry, P. MacMathuna, K. Younger, P.W. Keeling, J. Feely, Effect of zinc supplementation on oxidative drug metabolism in patients with hepatic cirrhosis, British Journal of Clinical Pharmacology, 31, 1991, p488 - 491
Etwebi, A.B., Comerford, F.R., Callaghan, M., Mulherin, D., Whelan, A., Feighery, C., FitzGerald, M.X., Bresnihan, B., Bell, A.L., Markey, G.M., Alexander, H.D., Morris, M., McNally, J.A., O'Byrne, S., Hall, M., Cuffe, J.T., Feely, J., Casey, E.B., de Paor, A., Reilly, R., Casey, E., McCormack, B., Kearns, G., Beirne, C., Ryan, D., Kearns, G.D., Casey, E.B., Nuallain, E.M., Reen, D.J., Kelleher, D., Murphy, A., Feighery, C., Casey, E.B., Cullen, D., Kelleher, D., Murphy, A., Keams, G., Feighery, C., Casey, E.B., Foley-Nolan, D., Brady, A., Stack, J., Barry, C., Ennis, J., Coughlan, R.J., Foley-Nolan, D., Murray, P., Campbell, E., Keogh, B., Coughlan, R.J., O'Donoghue, J., Foley-Nolan, D., Woods, R., Choudhry, L., Byrne, P., Barry, C., Coughlan, R.J., McCarthy, C.J., Regan, M., Coughlan, R.J., Barry, C., McCarthy, J., Coughlin, R.J., Barry, C., McCarthy, C., Foley-Nolan, D., Coughlan, R., Barry, C., Sant, T.J., Healy, S., Casey, E.B., Healy, E., Sant, S., Tyrrell, J., Casey, E.B., Sant, S., Barry, M., Murphy, G., Sant, S., Barry, M., Murphy, G., Veale, D., Rogers, S., Barnes, L., FitzGerald, O., Cooney, J., Veale, D., McQuillan, R., Leahy, A., Barton, J., McMahon, M., Bouchier-Hayes, C., Courtney, G., Doyle, J.S., FitzGerald, O., Taggart, A.J., McEvoy, F., Heylings, D., McMillin, P., Hassan, J., Yarani, G., Feighery, C., Bresnihan, B., Whelan, A., Doherty, E., Bresnihan, B., Harden, C., Feighery, C., Jackson, J., Yanni, G., Whelan, A., Feighery, C., Bresnihan, B., Yanni, G., Whelan, A., Feighery, C., FitzGerald, O., Breshihan, B., Shaw, B., FitzGerald, O., Irish association of Rheumatology & Rehabilitation - Proceedings of the annual general meeting, friday, 16th november, 1990, Irish Journal of Medical Science, 160, (1), 1991, p30-37
Feely, J., Holland, P., Barry, M., Genetic polymorphism in Ireland and influence of quinine tonic water on hydroxylation, British Journal of Clinical Pharmacology, 29, (5), 1990
M. Barry, F. Mulcahy, J.Feely, Zidovudine and Hepatic Oxidative Drug Metabolism, Drug Investment , 2, 1990, p200 - 202
M. Barry, J. Feely, Allopurinol Influences Aminophenazone Elimination, Clinical Pharmacokinetics , 19, 1990, p167 - 169
M. Barry, J. Feely, Enzyme Induction and Inhibition, Pharmacology and Therapeutics , 48, 1990, p71 - 94
M. Barry, PWN Keeling, D.G. Weir, J. Feely, Severity of cirrhosis and the relationship of a1 acid glycoprotein concentration to plasma protein binding of lidocaine, Clinical Pharmacology and Therapeutics, 47, 1990, p366 - 370
M. Barry, PWN Keeling, J. Feely, Tissue zinc status and drug elimination in patients with chronic liver disease, Clinical Science, 78, 1990, p547 - 549
P. MacMathuna, B. Foley, T. O'Reilly, M. Barry, PWN Keeling, J. Feely, Splanchnic and systemic haemodynamic effects of vasopressin and nifedipine in cirrhosis and portal hypertension, British Journal of Clinical Pharmacology, 25, 1988, pp621 - 622
A. Duenas Laita, M. Barry, P. MacMathuna, J. Feely, Effects of chronic treatment with amiodarone on hepatic demethylation and cytochrome P450, Journal of Pharmacy and Pharmacology, 39, 1987, p757 - 759
P. MacMathuna, T. O'Reilly, D. Kelleher, M. Barry, J. Feely, PWN Keeling, The effect of calcium channel blockade with nifedipine on splanchnic and systemic haemodynamics in cirrhosis, Alimentary Pharmacology and Therapeutics, 1, 1987, p639 - 642
J. Feely, Increase in renal cytochrome P450 and NADPH cytochrome c reductase activity following drug inhibition of hepatic mono-oxygenase activity, Biochemical Pharmacology, 36, 1987, p768 - 769
M. Barry, P. MacMathuna, J.C.S. de Azavedo, J. Feely, Toxic shock syndrome in a penicillin sensitive patient, Irish Journal of Medical Science, 156, 1986, p18 - 19
McLoughlin, P., McCaffrey, N., O"Regan, R.G., Hammad, M.K., Sheppard, B.L., Eaton, C., Bonnar, J., Whelan, J., Martin, F., Kane, M.T., Wilson, C.M., Dundee, J.W., Mathews, H.M.L., Moore, J., Feaklins, R., Andrews, J.F., Arbuthnott, E.R., Garvey, E., Bannigan, J., Hooper, A.C.B., Brien, T.G., Lawlor, P.G., Redmond, H.P., Redmond, J.M., Duignan, J.P., Waldron, D.J., Bowes, K.L., Given, H.F., O"Brien, L., Luckwill, R.G., Burke, M.C., McAvinchey, D., Waldron, R., Fitzpatrick, G.J., O"Malley, E., Ghaly, R.G., Lynas, A.G.A., Thompson, E.M., Fee, J.P.H., McClean, E., Carlisle, E.J.F., Kernohan, W.G., Allen, J.D., Bailey, A., Anderson, J., Adgey, A.A.J., Kennedy, M., Feely, S., Leek, B.F., Stafford, K.J., McCarron, J.G., Allen, J.M., Thornbury, K.D., McHale, N.G., Brady, H.R., Ryan, M.P., McDermott, M., Duenas-Laita, A., Barry, M.G., MacMathuna, P., Feely, J., Kelleher, P., Odumosu, A., Ganuza-Bidarte, M., Bell, P., McCaughey, W., Hawthorne, P., Bahendeka, S.K., Moore, R.E., Tobin, A.A.M., Barry, M., O"Reilly, T., Younger, K., Keeling, P.W.N., Harper, K.W., Collier, P.S., Collins, W.C.J., Cullen, M.J., McGirl, A., Dooley, E., Wilson, B.G., Odling-Smee, G.W., Howard, P.J., Royal academy of medicine in ireland section of biological sciences: Proceedings of meeting held on 3rd January, 1986., Irish Journal of Medical Science, 155, (9), 1986, p320-334